Cognitive and behavioral abnormalities in adenosine deaminase deficient severe combined immunodeficiency
- PMID: 11445793
- DOI: 10.1067/mpd.2001.115023
Cognitive and behavioral abnormalities in adenosine deaminase deficient severe combined immunodeficiency
Abstract
Objective: The objective was to evaluate the cognitive, behavioral, and neurodevelopmental function in patients with adenosine deaminase deficient severe combined immunodeficiency (ADA-SCID) and to compare the findings with those of a case control group of patients without ADA-SCID.
Study design: Case-matched pairs of patients with ADA-SCID (n = 11) and patients without ADA-SCID who had undergone bone marrow transplantation were recruited. Subjects were assessed by age-appropriate standard tests of intelligence, behavior, and neurodevelopment.
Results: Cognitive ability was not significantly different between the 2 groups, but patients with ADA-SCID showed a significant inverse correlation between deoxyadenosinetrisphosphate levels at diagnosis and IQ (P =.048). Behavioral assessment showed that patients with ADA-SCID functioned in the pathologic range on all domains, whereas mean scores for the control group were within normal limits. Behavioral impairment in patients with ADA-SCID also showed a significant positive correlation with age (P =.026).
Conclusions: Cognitive function in ADA deficiency is adversely affected by the severity of metabolic derangement at the time of diagnosis. In addition, patients with ADA-SCID have significant behavioral abnormalities after transplantation. These defects are not due to the transplant procedure but reflect the systemic nature of ADA deficiency. These findings have important implications for future medical and nonmedical management strategies.
Comment in
-
Effects of metabolic disorders on the brain: can these effects be reversed with bone marrow transplantation?J Pediatr. 2001 Jul;139(1):9-11. doi: 10.1067/mpd.2001.116696. J Pediatr. 2001. PMID: 11445784 No abstract available.
Similar articles
-
Effects of metabolic disorders on the brain: can these effects be reversed with bone marrow transplantation?J Pediatr. 2001 Jul;139(1):9-11. doi: 10.1067/mpd.2001.116696. J Pediatr. 2001. PMID: 11445784 No abstract available.
-
Hyperbilirubinemia and rapid fatal hepatic failure in severe combined immunodeficiency caused by adenosine deaminase deficiency (ADA-SCID).Klin Padiatr. 2011 Mar;223(2):85-9. doi: 10.1055/s-0030-1269916. Epub 2011 Jan 26. Klin Padiatr. 2011. PMID: 21271505
-
Adenosine deaminase deficiency: clinical expression, molecular basis, and therapy.Semin Hematol. 1998 Oct;35(4):291-8. Semin Hematol. 1998. PMID: 9801258 Review.
-
Severe combined immunodeficiency of reduced severity due to homozygosity for an adenosine deaminase missense mutation (Arg253Pro).Cell Immunol. 1993 Dec;152(2):383-93. doi: 10.1006/cimm.1993.1299. Cell Immunol. 1993. PMID: 8258146
-
[Gene therapy for adenosine deaminase deficiency].Hokkaido Igaku Zasshi. 1996 Jan;71(1):27-32. Hokkaido Igaku Zasshi. 1996. PMID: 8727372 Review. Japanese.
Cited by
-
Adenosine Deaminase (ADA)-Deficient Severe Combined Immune Deficiency (SCID) in the US Immunodeficiency Network (USIDNet) Registry.J Clin Immunol. 2020 Nov;40(8):1124-1131. doi: 10.1007/s10875-020-00857-9. Epub 2020 Sep 2. J Clin Immunol. 2020. PMID: 32880085 Free PMC article.
-
Consensus approach for the management of severe combined immune deficiency caused by adenosine deaminase deficiency.J Allergy Clin Immunol. 2019 Mar;143(3):852-863. doi: 10.1016/j.jaci.2018.08.024. Epub 2018 Sep 5. J Allergy Clin Immunol. 2019. PMID: 30194989 Free PMC article. Review.
-
Strimvelis® for Treating Severe Combined Immunodeficiency Caused by Adenosine Deaminase Deficiency: An Evidence Review Group Perspective of a NICE Highly Specialised Technology Evaluation.Pharmacoecon Open. 2019 Jun;3(2):151-161. doi: 10.1007/s41669-018-0102-3. Pharmacoecon Open. 2019. PMID: 30334168 Free PMC article. Review.
-
Alterations in the brain adenosine metabolism cause behavioral and neurological impairment in ADA-deficient mice and patients.Sci Rep. 2017 Jan 11;7:40136. doi: 10.1038/srep40136. Sci Rep. 2017. PMID: 28074903 Free PMC article.
-
Eosinophilia Associated with Disorders of Immune Deficiency or Immune Dysregulation.Immunol Allergy Clin North Am. 2015 Aug;35(3):523-44. doi: 10.1016/j.iac.2015.05.004. Immunol Allergy Clin North Am. 2015. PMID: 26209898 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials